Global Organ Preservation Solutions Market Overview

Organ Preservation Solutions Market size is projected to reach USD XX Million by 2028 from an estimated USD XX Million in 2021, growing at a CAGR of xx% globally.

Transplantation has become a global clinical activity thus; organ preservation has been of major importance. The relatively simple procedures were based on fundamental knowledge of low-temperature biology as it relates to organs outside the body. There has been a tremendous gain in knowledge of the sequelae of effects in preserved organs, as well as how dynamic intervention by perfusion can be employed to minimize injury and improve the quality of donated organs over the last decade. The need to transport donor organs from the center where surgical retrieval was performed to the implanting center, which may be many kilometers away, has been a central focus for organ preservation, as have the potentially harmful functional consequences of hypoxia once the organ has been deprived of normal blood supply. At the Peter Bent Brigham Hospital in December 1954, John Merrill and Joseph Murray performed the first successful organ transplantation between two identical twins. Since the introduction of the national database in 1988, 809,655 transplants had been recorded to the United Organ Sharing (UNOS) network as of June 2020. The growing awareness among individuals about organ donation is one of the major factors supporting the growth of the organ preservation market over the forecasted period.

Covid-19 Impact On Organ Preservation Solutions Market

The COVID-19 pandemic placed a tremendous burden on healthcare systems around the world, which have struggled to deal with the inflow of critically ill patients while also protecting healthcare personnel from the unnecessary danger of infection. Patients with end-stage organ illness benefit greatly from solid organ transplantation, including increased survival and quality of life. Despite the critical need for many waitlisted patients worldwide to get transplants, preliminary statistics reveal that transplantation procedures have been significantly reduced in several countries since the COVID-19 outbreak. The pandemic increased the risks for donor recovery teams. It has been reported that a team from a high-prevalence location exposed health care employees in the organ recovery operating room who later became infected with COVID-19 to an asymptomatic but COVID-19-positive health care worker. This prompted UNOS/OPTN, and later the American Society of Transplant Surgeons (ASTS), to make strong recommendations for more collaboration and dependence on local donor recovery teams. To summarize, there was a steep decline in organ donations but, with the growing vaccination, the rate of organ donation is expected to increase thus, supporting the growth of the market.

Market Segmentation

Players Covered in Organ Preservation Solutions market are :

• 21st Century Medicine
• TransMedics
• BioLife Solutions Inc.
• Dr. Franz Köhler Chemie GmbH
• Essential Pharmaceuticals LLC
• Paragonix Technologies
• Lifeline Scientific Inc.
• Preservation Solutions Inc.
• XVIVO Perfusion AB

Key Industry Developments of Organ Preservation Solutions Market

In July 2021, TransMedics Group Inc. announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for their OCSTM Lung Solution for use in cold storage transplants. The solution, which is also part of the company's OCS Lung System, is designed for hypothermic flushing, storage, and transportation of donor's lungs for transplantation.

In October 2021, XVIVO Perfusion AB announced the acquisition of Star Teams, an organ retrieval company based in the United States. Through the acquisition, XVIVO expands its product portfolio with value-added services in the organ transplantation business, positioning itself as the most comprehensive turnkey provider for transplant facilities and driving the use of machine perfusion.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Preservation Technique
 3.2 By Organ Type
 3.3 By End User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  3.5.1 Drivers
  3.5.2 Restraints
  3.5.3 Opportunities
  3.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 4: Organ Preservation Solutions Market by Preservation Technique
 4.1 Organ Preservation Solutions Market Overview Snapshot and Growth Engine
 4.2 Organ Preservation Solutions Market Overview
 4.3 Static Cold Storage
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size (2016-2028F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Static Cold Storage: Grographic Segmentation
 4.4 Hypothermic Machine Perfusion
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size (2016-2028F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Hypothermic Machine Perfusion: Grographic Segmentation
 4.5 Normothermic Machine Perfusion
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size (2016-2028F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Normothermic Machine Perfusion: Grographic Segmentation
 4.6 Others
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size (2016-2028F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Others: Grographic Segmentation

Chapter 5: Organ Preservation Solutions Market by Organ Type
 5.1 Organ Preservation Solutions Market Overview Snapshot and Growth Engine
 5.2 Organ Preservation Solutions Market Overview
 5.3 Kidneys
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Kidneys: Grographic Segmentation
 5.4 Liver
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Liver: Grographic Segmentation
 5.5 Lungs
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Lungs: Grographic Segmentation
 5.6 Heart
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Heart: Grographic Segmentation
 5.7 Other Organ
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Other Organ: Grographic Segmentation

Chapter 6: Organ Preservation Solutions Market by End User
 6.1 Organ Preservation Solutions Market Overview Snapshot and Growth Engine
 6.2 Organ Preservation Solutions Market Overview
 6.3 Transplant Centers
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Transplant Centers: Grographic Segmentation
 6.4 Hospitals
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Hospitals: Grographic Segmentation
 6.5 Specialty Clinics
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Specialty Clinics: Grographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Organ Preservation Solutions Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Ansoff Matrix
  7.1.5 Organ Preservation Solutions Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Organ Preservation Solutions Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 21ST CENTURY MEDICINE
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 TRANSMEDICS
 7.4 BIOLIFE SOLUTIONS INC.
 7.5 DR. FRANZ KÖHLER CHEMIE GMBH
 7.6 ESSENTIAL PHARMACEUTICALS LLC
 7.7 PARAGONIX TECHNOLOGIES
 7.8 LIFELINE SCIENTIFIC INC.
 7.9 PRESERVATION SOLUTIONS INC.
 7.10 XVIVO PERFUSION AB

Chapter 8: Global Organ Preservation Solutions Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Preservation Technique
  8.2.1 Static Cold Storage
  8.2.2 Hypothermic Machine Perfusion
  8.2.3 Normothermic Machine Perfusion
  8.2.4 Others
 8.3 Historic and Forecasted Market Size By Organ Type
  8.3.1 Kidneys
  8.3.2 Liver
  8.3.3 Lungs
  8.3.4 Heart
  8.3.5 Other Organ
 8.4 Historic and Forecasted Market Size By End User
  8.4.1 Transplant Centers
  8.4.2 Hospitals
  8.4.3 Specialty Clinics

Chapter 9: North America Organ Preservation Solutions Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Preservation Technique
  9.4.1 Static Cold Storage
  9.4.2 Hypothermic Machine Perfusion
  9.4.3 Normothermic Machine Perfusion
  9.4.4 Others
 9.5 Historic and Forecasted Market Size By Organ Type
  9.5.1 Kidneys
  9.5.2 Liver
  9.5.3 Lungs
  9.5.4 Heart
  9.5.5 Other Organ
 9.6 Historic and Forecasted Market Size By End User
  9.6.1 Transplant Centers
  9.6.2 Hospitals
  9.6.3 Specialty Clinics
 9.7 Historic and Forecast Market Size by Country
  9.7.1 U.S.
  9.7.2 Canada
  9.7.3 Mexico

Chapter 10: Europe Organ Preservation Solutions Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Preservation Technique
  10.4.1 Static Cold Storage
  10.4.2 Hypothermic Machine Perfusion
  10.4.3 Normothermic Machine Perfusion
  10.4.4 Others
 10.5 Historic and Forecasted Market Size By Organ Type
  10.5.1 Kidneys
  10.5.2 Liver
  10.5.3 Lungs
  10.5.4 Heart
  10.5.5 Other Organ
 10.6 Historic and Forecasted Market Size By End User
  10.6.1 Transplant Centers
  10.6.2 Hospitals
  10.6.3 Specialty Clinics
 10.7 Historic and Forecast Market Size by Country
  10.7.1 Germany
  10.7.2 U.K.
  10.7.3 France
  10.7.4 Italy
  10.7.5 Russia
  10.7.6 Spain

Chapter 11: Asia-Pacific Organ Preservation Solutions Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Preservation Technique
  11.4.1 Static Cold Storage
  11.4.2 Hypothermic Machine Perfusion
  11.4.3 Normothermic Machine Perfusion
  11.4.4 Others
 11.5 Historic and Forecasted Market Size By Organ Type
  11.5.1 Kidneys
  11.5.2 Liver
  11.5.3 Lungs
  11.5.4 Heart
  11.5.5 Other Organ
 11.6 Historic and Forecasted Market Size By End User
  11.6.1 Transplant Centers
  11.6.2 Hospitals
  11.6.3 Specialty Clinics
 11.7 Historic and Forecast Market Size by Country
  11.7.1 China
  11.7.2 India
  11.7.3 Japan
  11.7.4 Southeast Asia

Chapter 12: South America Organ Preservation Solutions Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Preservation Technique
  12.4.1 Static Cold Storage
  12.4.2 Hypothermic Machine Perfusion
  12.4.3 Normothermic Machine Perfusion
  12.4.4 Others
 12.5 Historic and Forecasted Market Size By Organ Type
  12.5.1 Kidneys
  12.5.2 Liver
  12.5.3 Lungs
  12.5.4 Heart
  12.5.5 Other Organ
 12.6 Historic and Forecasted Market Size By End User
  12.6.1 Transplant Centers
  12.6.2 Hospitals
  12.6.3 Specialty Clinics
 12.7 Historic and Forecast Market Size by Country
  12.7.1 Brazil
  12.7.2 Argentina

Chapter 13: Middle East & Africa Organ Preservation Solutions Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Preservation Technique
  13.4.1 Static Cold Storage
  13.4.2 Hypothermic Machine Perfusion
  13.4.3 Normothermic Machine Perfusion
  13.4.4 Others
 13.5 Historic and Forecasted Market Size By Organ Type
  13.5.1 Kidneys
  13.5.2 Liver
  13.5.3 Lungs
  13.5.4 Heart
  13.5.5 Other Organ
 13.6 Historic and Forecasted Market Size By End User
  13.6.1 Transplant Centers
  13.6.2 Hospitals
  13.6.3 Specialty Clinics
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Saudi Arabia
  13.7.2 South Africa

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ORGAN PRESERVATION SOLUTIONS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ORGAN PRESERVATION SOLUTIONS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ORGAN PRESERVATION SOLUTIONS MARKET COMPETITIVE RIVALRY
TABLE 005. ORGAN PRESERVATION SOLUTIONS MARKET THREAT OF NEW ENTRANTS
TABLE 006. ORGAN PRESERVATION SOLUTIONS MARKET THREAT OF SUBSTITUTES
TABLE 007. ORGAN PRESERVATION SOLUTIONS MARKET BY PRESERVATION TECHNIQUE
TABLE 008. STATIC COLD STORAGE MARKET OVERVIEW (2016-2028)
TABLE 009. HYPOTHERMIC MACHINE PERFUSION MARKET OVERVIEW (2016-2028)
TABLE 010. NORMOTHERMIC MACHINE PERFUSION MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. ORGAN PRESERVATION SOLUTIONS MARKET BY ORGAN TYPE
TABLE 013. KIDNEYS MARKET OVERVIEW (2016-2028)
TABLE 014. LIVER MARKET OVERVIEW (2016-2028)
TABLE 015. LUNGS MARKET OVERVIEW (2016-2028)
TABLE 016. HEART MARKET OVERVIEW (2016-2028)
TABLE 017. OTHER ORGAN MARKET OVERVIEW (2016-2028)
TABLE 018. ORGAN PRESERVATION SOLUTIONS MARKET BY END USER
TABLE 019. TRANSPLANT CENTERS MARKET OVERVIEW (2016-2028)
TABLE 020. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 021. SPECIALTY CLINICS MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA ORGAN PRESERVATION SOLUTIONS MARKET, BY PRESERVATION TECHNIQUE (2016-2028)
TABLE 023. NORTH AMERICA ORGAN PRESERVATION SOLUTIONS MARKET, BY ORGAN TYPE (2016-2028)
TABLE 024. NORTH AMERICA ORGAN PRESERVATION SOLUTIONS MARKET, BY END USER (2016-2028)
TABLE 025. N ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 026. EUROPE ORGAN PRESERVATION SOLUTIONS MARKET, BY PRESERVATION TECHNIQUE (2016-2028)
TABLE 027. EUROPE ORGAN PRESERVATION SOLUTIONS MARKET, BY ORGAN TYPE (2016-2028)
TABLE 028. EUROPE ORGAN PRESERVATION SOLUTIONS MARKET, BY END USER (2016-2028)
TABLE 029. ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 030. ASIA PACIFIC ORGAN PRESERVATION SOLUTIONS MARKET, BY PRESERVATION TECHNIQUE (2016-2028)
TABLE 031. ASIA PACIFIC ORGAN PRESERVATION SOLUTIONS MARKET, BY ORGAN TYPE (2016-2028)
TABLE 032. ASIA PACIFIC ORGAN PRESERVATION SOLUTIONS MARKET, BY END USER (2016-2028)
TABLE 033. ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA ORGAN PRESERVATION SOLUTIONS MARKET, BY PRESERVATION TECHNIQUE (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA ORGAN PRESERVATION SOLUTIONS MARKET, BY ORGAN TYPE (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA ORGAN PRESERVATION SOLUTIONS MARKET, BY END USER (2016-2028)
TABLE 037. ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 038. SOUTH AMERICA ORGAN PRESERVATION SOLUTIONS MARKET, BY PRESERVATION TECHNIQUE (2016-2028)
TABLE 039. SOUTH AMERICA ORGAN PRESERVATION SOLUTIONS MARKET, BY ORGAN TYPE (2016-2028)
TABLE 040. SOUTH AMERICA ORGAN PRESERVATION SOLUTIONS MARKET, BY END USER (2016-2028)
TABLE 041. ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 042. 21ST CENTURY MEDICINE: SNAPSHOT
TABLE 043. 21ST CENTURY MEDICINE: BUSINESS PERFORMANCE
TABLE 044. 21ST CENTURY MEDICINE: PRODUCT PORTFOLIO
TABLE 045. 21ST CENTURY MEDICINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. TRANSMEDICS: SNAPSHOT
TABLE 046. TRANSMEDICS: BUSINESS PERFORMANCE
TABLE 047. TRANSMEDICS: PRODUCT PORTFOLIO
TABLE 048. TRANSMEDICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. BIOLIFE SOLUTIONS INC.: SNAPSHOT
TABLE 049. BIOLIFE SOLUTIONS INC.: BUSINESS PERFORMANCE
TABLE 050. BIOLIFE SOLUTIONS INC.: PRODUCT PORTFOLIO
TABLE 051. BIOLIFE SOLUTIONS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. DR. FRANZ KÖHLER CHEMIE GMBH: SNAPSHOT
TABLE 052. DR. FRANZ KÖHLER CHEMIE GMBH: BUSINESS PERFORMANCE
TABLE 053. DR. FRANZ KÖHLER CHEMIE GMBH: PRODUCT PORTFOLIO
TABLE 054. DR. FRANZ KÖHLER CHEMIE GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. ESSENTIAL PHARMACEUTICALS LLC: SNAPSHOT
TABLE 055. ESSENTIAL PHARMACEUTICALS LLC: BUSINESS PERFORMANCE
TABLE 056. ESSENTIAL PHARMACEUTICALS LLC: PRODUCT PORTFOLIO
TABLE 057. ESSENTIAL PHARMACEUTICALS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. PARAGONIX TECHNOLOGIES: SNAPSHOT
TABLE 058. PARAGONIX TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 059. PARAGONIX TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 060. PARAGONIX TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. LIFELINE SCIENTIFIC INC.: SNAPSHOT
TABLE 061. LIFELINE SCIENTIFIC INC.: BUSINESS PERFORMANCE
TABLE 062. LIFELINE SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 063. LIFELINE SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. PRESERVATION SOLUTIONS INC.: SNAPSHOT
TABLE 064. PRESERVATION SOLUTIONS INC.: BUSINESS PERFORMANCE
TABLE 065. PRESERVATION SOLUTIONS INC.: PRODUCT PORTFOLIO
TABLE 066. PRESERVATION SOLUTIONS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. XVIVO PERFUSION AB: SNAPSHOT
TABLE 067. XVIVO PERFUSION AB: BUSINESS PERFORMANCE
TABLE 068. XVIVO PERFUSION AB: PRODUCT PORTFOLIO
TABLE 069. XVIVO PERFUSION AB: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ORGAN PRESERVATION SOLUTIONS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ORGAN PRESERVATION SOLUTIONS MARKET OVERVIEW BY PRESERVATION TECHNIQUE
FIGURE 012. STATIC COLD STORAGE MARKET OVERVIEW (2016-2028)
FIGURE 013. HYPOTHERMIC MACHINE PERFUSION MARKET OVERVIEW (2016-2028)
FIGURE 014. NORMOTHERMIC MACHINE PERFUSION MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. ORGAN PRESERVATION SOLUTIONS MARKET OVERVIEW BY ORGAN TYPE
FIGURE 017. KIDNEYS MARKET OVERVIEW (2016-2028)
FIGURE 018. LIVER MARKET OVERVIEW (2016-2028)
FIGURE 019. LUNGS MARKET OVERVIEW (2016-2028)
FIGURE 020. HEART MARKET OVERVIEW (2016-2028)
FIGURE 021. OTHER ORGAN MARKET OVERVIEW (2016-2028)
FIGURE 022. ORGAN PRESERVATION SOLUTIONS MARKET OVERVIEW BY END USER
FIGURE 023. TRANSPLANT CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 024. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 025. SPECIALTY CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA ORGAN PRESERVATION SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE ORGAN PRESERVATION SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC ORGAN PRESERVATION SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA ORGAN PRESERVATION SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA ORGAN PRESERVATION SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)

Please Wait...